PATENT CLAIM ANALYSIS

Application Number: 16192162
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["546", "273400"]

Abstract:
Novel benzimidazole enantiomeric derivatives, their process of preparation and their therapeutical uses as dual H1 and H4 receptor ligands are disclosed.

Claim (Index 10):
A combination comprising a compound according to  claim 1  with a H1R antagonist.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 98.0
- Lexical Diversity: 1.09524
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13825989', '14317024', '13910651', '10582564', '14058164']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7551725032989712
- 35 USC 102 Novelty (BERT): 0.5436110174171357
- Combined Prediction Score: 0.7340163547107877
- Mean Citation Score: 322.902672
- Max Citation Score: 392.15402
- Similarity Product: 300.881411238637

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test